SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-015812
Filing Date
2023-04-28
Accepted
2023-04-28 16:13:35
Documents
6
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A nuvl-def_14a-2023_from_p.htm DEF 14A 1124933
2 GRAPHIC img91182178_0.jpg GRAPHIC 63413
3 GRAPHIC img91182178_1.jpg GRAPHIC 6617
4 GRAPHIC img91182178_2.jpg GRAPHIC 63413
5 GRAPHIC img91182178_3.jpg GRAPHIC 1311149
6 GRAPHIC img91182178_4.jpg GRAPHIC 1074379
  Complete submission text file 0000950170-23-015812.txt   4594700
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40671 | Film No.: 23866300
SIC: 2834 Pharmaceutical Preparations